$SKIN Cashflow Statement | Understand Stock

$SKIN

$10.12 -$0.40 (3.8%) Close

$SKIN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash from operating activities
Share-based compensation
Amortization of unfavorable lease terms
Write-off of unfavorable lease
Loss on sale and disposal of long-lived assets
In-kind interest
Deferred income tax benefit
Amortization of intangible assets
Depreciation of property and equipment
Amortization of capitalized software
Amortization of other assets
Amortization of debt issuance costs
Inventory write-down
Syndeo inventory write-down
Provision for estimated credit losses
Non-cash lease expense
Change in fair value of warrant liabilities
Debt prepayment expense
Foreign currency transactions
Change in fair value adjustment of earn-out shares
Gain on exchange and repurchases of convertible senior notes, net
Deferred income taxes
Other, net
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Other assets
Income taxes receivable
Prepaid expenses, other current assets, and income tax receivable
Accounts payable
Other long-term liabilities
Lease liabilities
Accrued payroll and other expenses
Income taxes payable
Accounts payable, accrued expenses, and income tax payable
Other, net

Net cash provided by operating activities
Cash flows from investing activities:
Cash paid for intangible assets
Cash paid for property and equipment
Cash paid for asset acquisitions
Cash paid for business acquisition
Other, net
Net cash used for investing activities
Cash flows from financing activities:
Repurchase of 2026 Notes in connection with exchange
Issuance of 2028 Notes in connection with exchange, net
Purchase of capped calls related to convertible senior notes
Proceeds from exercise of warrants
Proceeds from revolving facility
Repayment of revolving facility
Proceeds from term loan
Payment of debt issuance costs
Repayment of term loan
Payments for transaction costs
Deferred payment for acquisition
Proceed from Business Combination
Repurchase of 2026 Notes
Payment of tax withholdings on vested stock awards
Repurchase of common stock
Payment of accelerated share repurchases
Payment of contingent considerations related to acquisitions
Other, net
Net cash used for financing activities

Net change in cash, cash equivalents, and restricted cash
Effect of foreign currency translation on cash
Cash, cash equivalents, and restricted cash beginning of period
Cash, cash equivalents, and restricted cash end of period
Supplemental disclosures of cash flow information and non-cash investing activities:
Cash paid for interest
Cash paid (received) for income taxes
Capital expenditures included in accounts payable
Deferred payment due to seller related business acquisition
Issuance of earn-out shares
Trade receivables due from seller
Notes payable to seller
Contingent consideration
Issuance of Class A Common Stock in connection with business acquisitions
Deferred unpaid offering costs
Class A Common Stock issued for asset acquisition

Comments